Healthcare & Life Sciences
Sudo Biosciences
United Statessudobio.com
Sudo Biosciences is a Healthcare & Life Sciences startup based in the United States, most recent round Series B.
series-b
series-b
Stage
About Sudo Biosciences
Based in the United States, Sudo Biosciences is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences.
Sudo Biosciences is a clinical-stage neuro-immunology biotechnology company developing small-molecule TYK2 inhibitors for neurological and immune-mediated inflammatory diseases such as multiple sclerosis and psoriasis. The company advances brain-penetrant and allosteric TYK2 programs through preclinical and early clinical development.
Explore Sudo Biosciences's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.